1. FDA grants Bristol-Myers priority review for ide-cel — Is Illumina making an $8B blunder? — Medicare may not cover the cost of the coronavirus vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Reps leaving

Discussion in 'MWI' started by Anonymous, Nov 20, 2014 at 6:14 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    The last rep that left has relationships with his customers. it will be clear in coming months. he is a good rep.
     

  2. Anonymous

    Anonymous Guest

    Thank you for your very informative post.